Company Filing History:
Years Active: 2024-2025
Title: Chris A Reid: Innovator in Gene Therapy
Introduction
Chris A Reid is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. With a total of 2 patents, Reid's work is paving the way for innovative medical solutions.
Latest Patents
Reid's latest patents include a groundbreaking invention titled "Riboswitch modulated gene therapy for retinal diseases." This invention provides constructs comprising modified riboswitches to regulate the expression of a transgene within a subject. The methods outlined in this patent aim to treat diseases, specifically eye diseases, showcasing Reid's commitment to advancing medical science.
Career Highlights
Chris A Reid is affiliated with the Medical College of Wisconsin, Inc., where he continues to push the boundaries of research and innovation. His work is characterized by a focus on developing novel therapeutic approaches that can significantly impact patient care.
Collaborations
Reid collaborates with esteemed colleagues, including Daniel M Lipinski, to enhance the scope and effectiveness of his research. Their combined expertise contributes to the advancement of gene therapy techniques.
Conclusion
Chris A Reid's contributions to gene therapy exemplify the spirit of innovation in the medical field. His patents and collaborative efforts are vital in the ongoing quest to improve treatments for retinal diseases.